Figure 1From: Oral Adsorbent AST-120 Decreases Serum Levels of AGEs in Patients with Chronic Renal FailureEffects of oral administration of AST-120 on serum levels of AGEs in patients with nondiabetic CRF. ○, AST-treated patients (n = 10); ●, control patients without AST treatment (n = 6). *P < 0.05 compared with the value before treatment.Back to article page